Spotlight on Rituximab in Chronic Lymphocytic Leukemia, Low-Grade or Follicular Lymphoma, and Diffuse Large B-Cell Lymphoma†

Author： Keating Gillian M.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.25, Iss.1, 2011-02, pp. : 55-61

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Rituximab in Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

By Cvetković Risto S.   Perry Caroline M.  

BioDrugs, Vol. 20, Iss. 4, 2006-01 ,pp. : 253-257

Adis International

Access to resources Recommend Favorite

Cutaneous diffuse large B‐cell lymphoma

By  

Clinical Case Reports, Vol. 6, Iss. 1, 2018-01 ,pp. : 228-229

John Wiley & Sons Inc

Access to resources Recommend Favorite

Leukemic phase and CSF involvement of diffuse large B‐cell lymphoma with a complex karyotype including a TP53 deletion

By  

Clinical Case Reports, Vol. 6, Iss. 1, 2018-01 ,pp. : 235-237

John Wiley & Sons Inc

Access to resources Recommend Favorite

Primary rectal diffuse large B‐cell lymphoma associated with ulcerative colitis: a case report

By  

Clinical Case Reports, Vol. 3, Iss. 3, 2015-03 ,pp. : 150-155

John Wiley & Sons Inc

Access to resources Recommend Favorite

Primary pleural precursor B‐Cell lymphoblastic lymphoma

By  

Clinical Case Reports, Vol. 3, Iss. 10, 2015-10 ,pp. : 858-861

John Wiley & Sons Inc

Access to resources Recommend Favorite